Page 85 | Certara

Announcement

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Formedix ryze cloud based clinical metadata repository and SDTM automation suite and Certara Pinnacle 21…

CertaraOctober 10, 2023

Blog

Do the Scale-up & Post approval Changes (SUPAC) Guidance Documents Still Apply to Drug Developers?

Do you remember the 1990s? The Soviet Union fell, Friends was the most popular TV…

CertaraOctober 6, 2023

Conference

GMP 2024 Symposium

CertaraOctober 5, 2023

Announcement

Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform

Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October…

CertaraOctober 5, 2023

Publication

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model

Hugo Geerts, Silke Bergeler, Mike Walker, Piet van der Graaf, Jean-Philippe Courade. Sci Rep. 2023…

CertaraOctober 5, 2023

Press Coverage

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Regulatory guidance paves the way to address ethical concerns in pediatric trials, and how additional…

CertaraOctober 5, 2023

On-Demand Webinar

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development…

CertaraOctober 4, 2023

Announcement

Certara Launches CoAuthor, a Regulatory and Medical Writing Tool

Using AI to gain efficiencies for medical writers PRINCETON, N. J.— October 3, 2023— Certara,…

CertaraOctober 3, 2023

Case Study

Accelerating a drug launch with value communication technology and an integrated workflow

With early approvals for a targeted cancer drug in Brazil and Argentina, this global pharmaceutical…

CertaraOctober 2, 2023

Case Study

Medical Device | Medtronic Demonstrating the economic value of minimally invasive spinal surgery on the iPad

This case study describes the use of a web-based platform to demonstrate the value of…

CertaraOctober 2, 2023

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Do the Scale-up & Post approval Changes (SUPAC) Guidance Documents Still Apply to Drug Developers?

GMP 2024 Symposium

Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

Certara Launches CoAuthor, a Regulatory and Medical Writing Tool

Accelerating a drug launch with value communication technology and an integrated workflow

Medical Device | Medtronic Demonstrating the economic value of minimally invasive spinal surgery on the iPad

Newsletter sign up

Quick links

Solutions

Contact